Clinical Trials
59 trialsTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
PANEX3
University Hospital, Caen
Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy
Region Stockholm
High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)
Beth Israel Deaconess Medical Center
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
Massachusetts General Hospital
RESTODIG
Assistance Publique Hopitaux De Marseille
POPHaH
Nordsjaellands Hospital
Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis
Weill Medical College of Cornell University
COMET
Centre Hospitalier Universitaire, Amiens
DUET
Janssen Research & Development, LLC
AZITRATIM
Rambam Health Care Campus
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Janssen Scientific Affairs, LLC
FREE
University Medical Center Groningen
TAP-DEX
University of Saskatchewan
Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition
Hospital Galdakao-Usansolo
VEDO-PREDIRESP
Centre Hospitalier Universitaire de Saint Etienne
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Alliance Foundation Trials, LLC.
PACEinMM-QC
Université de Sherbrooke
LADI
Radboud University Medical Center
OMNI-Can
OMNI Medical Services, LLC
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
University of Alabama at Birmingham
TRUE
Assistance Publique - Hôpitaux de Paris
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
AstraZeneca
Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease
AstraZeneca
TINGLE
Cedars-Sinai Medical Center
Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis
Charite University, Berlin, Germany
Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis
Charite University, Berlin, Germany
AVOID
Leiden University Medical Center
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
Charite University, Berlin, Germany
VIRTUOSO
Portsmouth Hospitals NHS Trust
PPaM
The Cleveland Clinic
Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease
Karolinska University Hospital
Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease
AbbVie
PILLAR II
Novadaq Technologies ULC, now a part of Stryker
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
UCB Pharma
Welcome2
UCB Pharma
ENMSET
Evangelisches Krankenhaus Düsseldorf
Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease
Ohio State University Comprehensive Cancer Center
Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis
Beijing Friendship Hospital
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
Janssen Research & Development, LLC
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
National Institutes of Health Clinical Center (CC)
Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease
Radboud University Medical Center
DYDJI
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease
Novartis
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
FDA Office of Orphan Products Development
Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery
University Hospitals Cleveland Medical Center
Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
Atlanta VA Medical Center
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Mayo Clinic
FACC
French Society of Coloproctology